SCHEMBL7367599

SCHEMBL7367599

OC(c1ccc(Br)nc1)c1ccc(OC(F)F)c(OC(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 20/20 0.43
KCNH2 Q12809 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5942690 0.83 PDE4A (0.40) PDE4AKCNH2
SCHEMBL7395938 0.78 PDE4A (0.51) PDE4AKCNH2
SCHEMBL7908346 0.75 PDE4A (0.67) PDE4AKCNH2
SCHEMBL7908376 0.73 PDE4A (0.44) PDE4A
SCHEMBL7989179 0.73 PDE4A (0.37) PDE4AKCNH2
SCHEMBL7908336 0.73 PDE4A (0.38) PDE4AKCNH2
SCHEMBL5942728 0.72 PDE4A (0.52) PDE4AKCNH2
SCHEMBL10633324 0.72 NR3C1 (0.41)
SCHEMBL7906572 0.71 PDE4A (0.51) PDE4AKCNH2
SCHEMBL7991261 0.71 HSPB1 (0.48) PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1189888-A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS $i(PDE 4) INHIBITORS Merck Frosst Canada & Co. (CA) 2002-03-27 EP disclosed
US-6316472-B1 Heterosubstituted pyridine derivatives as PDE 4 inhibitors MERCK FROSST CANADA & CO. (CA) 2001-11-13 US disclosed
US-6200993-B1 ASTHMA; ANTIINFLAMMATORY AGENTS MERCK FROSST CANADA & CO. (CA) 2001-03-13 US disclosed
US-6180650-B1 ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTITUMOR AGENTS MERCK FROSST CANADA & CO. (CA) 2001-01-30 US disclosed
WO-2000069824-A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS PDE 4 INHIBITORS MERCK FROSST CANADA & CO. (CA) 2000-11-23 WO disclosed